Heartflow, Inc. Common Stock (HTFL) Research

HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.

Market snapshot

Symbol
HTFL
Price
$33.64
Day change
+2.44%
Market cap
$2.9B
P/E ratio
-110.87x
52-week range
20.13-41.223
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 2 months
Analyst price target
$37.00

Peer companies

  • Alphatec Holdings, Inc. (ATEC)
  • Disc Medicine, Inc. (IRON)
  • Legend Biotech Corporation (LEGN)
  • LivaNova PLC (LIVN)
  • Perrigo Company plc (PRGO)
  • Privia Health Group, Inc. (PRVA)
  • Surgery Partners, Inc. (SGRY)
  • Tarsus Pharmaceuticals, Inc. (TARS)

Recent insider activity

  • WELDON WILLIAM C — A-Award (16075 shares) on 2026-06-16
  • BARABE TIMOTHY C — A-Award (16075 shares) on 2026-06-16
  • Cullivan Julie A — A-Award (16075 shares) on 2026-06-16
  • Lightcap Jeffrey C — A-Award (16075 shares) on 2026-06-16
  • Riley Wayne Joseph — A-Award (16075 shares) on 2026-06-16

Open Heartflow, Inc. Common Stock (HTFL) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.